From the Desk of the CEO

In this blog, APhA CEO Michael Hogue reflects on the evolving nature of science and APhA’s role in championing evidence-based practice.

APhA CEO Michael Hogue makes the case for why direct-to-consumer drug programs must include pharmacists’ care — and why leaving them out would be a costly mistake.

In this blog, APhA CEO Michael Hogue shares how the Association is doubling down on its commitment to pharmacy workforce well-being and workplace conditions. He highlights investments in staff expertise, new partnerships like HealthShifts to tackle staffing challenges, advocacy for patient safety and sustainable reimbursement, and real solutions to support pharmacists on the frontlines.

For over 130 years, health care professionals have been called upon as patriots caring for our nation’s wounded military. First purposed by President John Adams to provide “relief and maintenance of sick or disabled seamen,” what is now the U.S. Public Health Service (PHS) has taken on far expanded roles and responsibilities in our society. For example, following Hurricanes Andrew and Katrina, PHS health care professionals established field hospitals and pharmacies, supported local health care efforts, and provided access to clean water, vital vaccines, and much more.

Like so many of you, we’ve been continuing to follow reports in the media about pharmacy closures. It seems like each of those stories focuses on the obvious downside to the closures—a local place to get prescriptions filled is going away. While the inconvenience of having to get prescriptions filled miles away can be substantial